Harpoon therapeutics, inc. (HARP)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Revenue
Total revenue

8,011

5,777

4,606

4,252

4,252

4,750

0

0

0

-

-

-

-

Collaboration and license revenue

-

-

-

-

-

-

-

-

-

0

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

0

-

-

-

Operating expenses
Research and development

44,729

41,592

37,603

34,037

30,217

26,368

22,442

20,351

17,001

13,622

0

0

0

General and administrative

20,473

22,392

20,274

13,723

10,956

6,106

4,803

3,873

3,753

3,614

0

0

0

Total operating expenses

65,202

63,984

57,877

47,760

41,173

32,474

27,245

24,224

20,754

17,236

0

0

0

Loss from operations

-57,191

-58,207

-53,271

-43,508

-36,921

-27,724

-22,850

-20,892

-18,485

-16,528

0

0

0

Interest income

2,684

2,676

2,292

1,672

898

395

304

209

145

78

0

0

0

Interest expense

-

-

-

-

-

-

-

-

-

-

-

0

0

Other expense

0

-

-

-

0

-

-

-

-

0

0

-

0

Net loss

-54,545

-55,572

-51,032

-41,886

-36,063

-27,367

0

0

0

-

-

-

-

Other comprehensive loss:
Net unrealized gain on marketable securities

447

43

0

0

0

-

-

-

-

-

-

-

-

Comprehensive loss

-54,098

-55,529

0

0

0

-

-

-

-

-

-

-

-

Net loss and comprehensive loss

-

-

-

-

-

-

-

-

-

-16,830

0

0

0

Net loss per share, basic and diluted

-0.51

-0.58

-0.65

-0.49

-0.92

-8.15

-6.23

-5.89

-5.04

-5.27

-5.35

-4.24

-3.86

Weighted-average common shares used in computing net loss per share, basic and diluted

24,825

24,606

24,457

24,294

14,750

1,193

1,084

1,017

969

938

912

886

840

Collaboration and License
Total revenue

8,011

5,777

4,606

4,252

4,252

4,750

0

0

0

-

-

-

-